Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.71 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.71 |
| ▸ | TSHR | P16473 | 2/20 | 0.71 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.71 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.56 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.53 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.53 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.50 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.50 |
| ▸ | HPGDS | O60760 | 1/20 | 0.49 |
| ▸ | MEN1 | O00255 | 1/20 | 0.48 |
| ▸ | MITF | O75030 | 1/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
| ▸ | POLB | P06746 | 1/20 | 0.48 |
| ▸ | HPGD | P15428 | 1/20 | 0.48 |
| ▸ | SMARCA2 | P51531 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.48 |
| ▸ | KDM1A | O60341 | 1/20 | 0.48 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.47 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5024894 | 0.87 | ALDH1A1 (0.76) | ALDH1A1L3MBTL1TSHRALOX15KDM4E | |
| SCHEMBL5028870 | 0.85 | ALDH1A1 (0.74) | ALDH1A1L3MBTL1TSHRALOX15KDM4E | |
| SCHEMBL31232707 | 0.83 | ALDH1A1 (0.67) | ALDH1A1L3MBTL1TSHRALOX15KDM4E | |
| SCHEMBL5024742 | 0.83 | L3MBTL1 (1.00) | ALDH1A1L3MBTL1TSHRALOX15KDM4E | |
| SCHEMBL31232857 | 0.81 | ALDH1A1 (0.67) | ALDH1A1L3MBTL1TSHRALOX15KDM4E | |
| SCHEMBL6025900 | 0.80 | KDM4E (0.52) | ALDH1A1KDM4ECHRM2POLB | |
| SCHEMBL8263284 | 0.80 | POLB (0.47) | ALDH1A1L3MBTL1TSHRALOX15KDM4E | |
| SCHEMBL31232811 | 0.79 | ALDH1A1 (0.62) | ALDH1A1L3MBTL1TSHRALOX15KDM4E | |
| SCHEMBL31232859 | 0.79 | ALDH1A1 (0.62) | ALDH1A1L3MBTL1TSHRALOX15KDM4E | |
| Hydrochloric Acid SCHEMBL29740742 | 0.79 | KDM4E (0.54) | ALDH1A1KDM4ECHRM2POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1456337-B1 | USE OF SUPPORT-FIXED BLEACHING CATALYST COMPLEX COMPOUNDS AS CATALYSTS FOR PEROXIDE COMPOUNDS | HENKEL KGAA (DE) | 2007-01-24 | — | — | EP | claimed |
| EP-1531193-A2 | Method for deoyxgenating water | Henkel Kommanditgesellschaft auf Aktien (DE) | 2005-05-18 | — | — | EP | claimed |
| EP-1456337-A1 | SUPPORT-FIXED BLEACHING CATALYST COMPLEX COMPOUNDS SUITABLE AS CATALYSTS FOR PEROXIDE COMPOUNDS | Henkel Kommanditgesellschaft auf Aktien (DE) | 2004-09-15 | — | — | EP | claimed |
| WO-2003054128-A1 | SUPPORT-FIXED BLEACHING CATALYST COMPLEX COMPOUNDS SUITABLE AS CATALYSTS FOR PEROXIDE COMPOUNDS | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2003-07-03 | — | — | WO | claimed |
| US-11492302-B2 | Integrated capture and conversion of CO2 to methane, methanol, or methanol and glycol | BATTELLE MEMORIAL INSTITUTE (US) | 2022-11-08 | — | — | US | disclosed |
| US-20210214287-A1 | INTEGRATED CAPTURE AND CONVERSION OF CO2 TO METHANE, METHANOL, OR METHANOL AND GLYCOL | BATTELLE MEMORIAL INSTITUTE (US) | 2021-07-15 | — | — | US | disclosed |
| US-20080207645-A1 | Pyridothienopyrimidine Derivatives | PAGES SANTACANA LUIS MIGUEL | 2008-08-28 | — | — | US | disclosed |
| US-7335629-B2 | Support-fixed bleaching catalyst complex compounds suitable as catalysts for peroxygen compounds | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2008-02-26 | — | — | US | disclosed |
| US-7335629-B2 | Support-fixed bleaching catalyst complex compounds suitable as catalysts for peroxygen compounds | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2008-02-26 | — | — | US | disclosed |
| EP-1819712-A1 | NEW PYRIDOTHIENOPYRIMIDINE DERIVATIVES | Laboratorios Almirall, S.A. (ES) | 2007-08-22 | — | — | EP | disclosed |
| EP-1456337-B1 | USE OF SUPPORT-FIXED BLEACHING CATALYST COMPLEX COMPOUNDS AS CATALYSTS FOR PEROXIDE COMPOUNDS | HENKEL KGAA (DE) | 2007-01-24 | — | — | EP | disclosed |
| WO-2006058723-A1 | NEW PYRIDOTHIENOPYRIMIDINE DERIVATIVES | LABORATORIOS ALMIRALL, S.A. (ES) | 2006-06-08 | — | — | WO | disclosed |
| EP-1531193-A2 | Method for deoyxgenating water | Henkel Kommanditgesellschaft auf Aktien (DE) | 2005-05-18 | — | — | EP | disclosed |
| EP-1456337-A1 | SUPPORT-FIXED BLEACHING CATALYST COMPLEX COMPOUNDS SUITABLE AS CATALYSTS FOR PEROXIDE COMPOUNDS | Henkel Kommanditgesellschaft auf Aktien (DE) | 2004-09-15 | — | — | EP | disclosed |
| WO-2003054128-A1 | SUPPORT-FIXED BLEACHING CATALYST COMPLEX COMPOUNDS SUITABLE AS CATALYSTS FOR PEROXIDE COMPOUNDS | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2003-07-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210214287-A1 | INTEGRATED CAPTURE AND CONVERSION OF CO2 TO METHANE, METHANOL, OR METHANOL AND GLYCOL | MSMO1, ADH1C, MCCC2 | ALDH1A1 2715/4885L3MBTL1 3548/4885TSHR 4283/4885 |
| US-11492302-B2 | Integrated capture and conversion of CO2 to methane, methanol, or methanol and glycol | MSMO1, ADH1C, MCCC2 | ALDH1A1 2715/4885L3MBTL1 3548/4885TSHR 4283/4885 |
| US-20080207645-A1 | Pyridothienopyrimidine Derivatives | PDE4A, PDE5A, PDE3B | ALDH1A1 438/4885L3MBTL1 4256/4885TSHR 2629/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.